Efficacy and safety of switching from sitagliptin to liraglutide in subjects with type 2 diabetes (<scp>LIRA‐SWITCH</scp>): a randomized, double‐blind, double‐dummy, active‐controlled 26‐week trial
Diabetes, obesity & metabolism/Diabetes, obesity and metabolism